These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
951 related items for PubMed ID: 23269991
1. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, Guo RP, Zhang YQ, Lau WY. J Clin Oncol; 2013 Feb 01; 31(4):426-32. PubMed ID: 23269991 [Abstract] [Full Text] [Related]
2. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors]. Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH. Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768 [Abstract] [Full Text] [Related]
3. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS. Radiology; 2012 Feb 10; 262(2):689-700. PubMed ID: 22157201 [Abstract] [Full Text] [Related]
7. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma. Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK. Korean J Intern Med; 2016 Mar 10; 31(2):242-52. PubMed ID: 26874512 [Abstract] [Full Text] [Related]
8. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm]. Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW. Korean J Hepatol; 2009 Dec 10; 15(4):474-85. PubMed ID: 20037266 [Abstract] [Full Text] [Related]
9. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL, Yi CH. JAMA; 2008 Apr 09; 299(14):1669-77. PubMed ID: 18398079 [Abstract] [Full Text] [Related]
10. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study. Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T. J Gastroenterol Hepatol; 2008 Mar 09; 23(3):482-90. PubMed ID: 18086115 [Abstract] [Full Text] [Related]
11. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T, Tokai RFA Study Group. Cancer; 2010 Aug 01; 116(15):3638-44. PubMed ID: 20564097 [Abstract] [Full Text] [Related]
12. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K. Radiology; 2009 Sep 01; 252(3):905-13. PubMed ID: 19567647 [Abstract] [Full Text] [Related]
13. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation]. Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS. Ai Zheng; 2005 Jul 01; 24(7):827-33. PubMed ID: 16004809 [Abstract] [Full Text] [Related]
14. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma. Xu RC, Liu HC, Li JL, Li K, Ou SY, Yu ZY, Kong Y, Ma GA, Shao WS. Curr Med Res Opin; 2015 Aug 01; 31(8):1553-60. PubMed ID: 26067770 [Abstract] [Full Text] [Related]
15. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma. Peng ZW, Chen MS. Oncology; 2013 Aug 01; 84 Suppl 1():40-3. PubMed ID: 23428857 [Abstract] [Full Text] [Related]
16. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone. Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN. Eur J Radiol; 2012 Mar 01; 81(3):e189-93. PubMed ID: 21353417 [Abstract] [Full Text] [Related]
17. Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact. Utsunomiya T, Shimada M, Kudo M, Ichida T, Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Kokudo N, Makuuchi M, Liver Cancer Study Group of Japan. Ann Surg; 2014 Feb 01; 259(2):336-45. PubMed ID: 23673768 [Abstract] [Full Text] [Related]
18. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Wang W, Shi J, Xie WF. Liver Int; 2010 May 01; 30(5):741-9. PubMed ID: 20331507 [Abstract] [Full Text] [Related]
19. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma. Yang DJ, Luo KL, Liu H, Cai B, Tao GQ, Su XF, Hou XJ, Ye F, Li XY, Tian ZQ. Oncotarget; 2017 Jan 10; 8(2):2960-2970. PubMed ID: 27936465 [Abstract] [Full Text] [Related]
20. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Zhang YJ, Liang HH, Chen MS, Guo RP, Li JQ, Zheng Y, Zhang YQ, Lau WY. Radiology; 2007 Aug 10; 244(2):599-607. PubMed ID: 17641378 [Abstract] [Full Text] [Related] Page: [Next] [New Search]